David J. Arthur, during the interview with CEOCFO’s Senior Editor Lynn Fosse, addressing the concept behind NanOlogy said, “NanOlogy is a clinical-stage oncology company advancing a technology ...
CEOCFO interviews NanOlogy, LLC CEO David J. Arthur on Solving Toxicity & Bioavailability Problems when Treating Cancer FORT WORTH, TX, UNITED STATES, February 26 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results